Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety: Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06337604
What this trial is testing

The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets

Who this might be right for
Helicobacter Pylori Infection
TenNor Therapeutics Inc. 20
Early research (Phase 1)Study completedNCT05293678
What this trial is testing

Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody/Ies in Adult Healthy Volunteers as Related to COVID-19

Who this might be right for
Healthy
Regeneron Pharmaceuticals 104
Not applicableStudy completedNCT01897285
What this trial is testing

A Single Centre, Randomised, Comparative, Blinded Wear Test of Two Adhesives on the AQUACEL® Foam Adhesive Dressing

Who this might be right for
Safety and Performance of Dressing Adhesive on Healthy Volunteers
ConvaTec Inc. 20
Early research (Phase 1)Study completedNCT02063204
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

Who this might be right for
Solid Tumours
AstraZeneca 24
Early research (Phase 1)Study completedNCT07051538
What this trial is testing

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 64
Early research (Phase 1)Study completedNCT01899755
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Who this might be right for
Psoriasis
GlaxoSmithKline 45
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Early research (Phase 1)Not Yet RecruitingNCT07399899
What this trial is testing

Dose-Finding Study of NBX-100 in Healthy Adult Participants

Who this might be right for
Healthy Participants
Neurala Biosciences 8
Early research (Phase 1)Study completedNCT01983358
What this trial is testing

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

Who this might be right for
Stroke
Jeil Pharmaceutical Co., Ltd. 40
Early research (Phase 1)Study completedNCT06933043
What this trial is testing

A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults.

Who this might be right for
Healthy Volunteers
Navigator Medicines, Inc. 24
Early research (Phase 1)Active Not RecruitingNCT06309043
What this trial is testing

A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects

Who this might be right for
EGFR Overexpression
Shanghai Henlius Biotech 268
Early research (Phase 1)UnknownNCT05432544
What this trial is testing

Safety and Tolerability of SHR-1918 in Healthy Subjects

Who this might be right for
Hyperlipemia
Beijing Suncadia Pharmaceuticals Co., Ltd 72
Early research (Phase 1)Study completedNCT05238493
What this trial is testing

A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101

Who this might be right for
Healthy Volunteers
Veloxis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT03554993
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects

Who this might be right for
Healthy Volunteer
Celgene 97
Early research (Phase 1)Study completedNCT06475404
What this trial is testing

The Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Who this might be right for
Mucopolysaccharidosis Type IIMetabolic Diseases
AO GENERIUM 18
Early research (Phase 1)Ended earlyNCT02447458
What this trial is testing

MLN3126 Single Rising Dose Study

Who this might be right for
Healthy Volunteers
Takeda 39
Early research (Phase 1)Ended earlyNCT01096563
What this trial is testing

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 27
Early research (Phase 1)Ended earlyNCT02072993
What this trial is testing

A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

Who this might be right for
Healthy Subjects
AstraZeneca 116
Early research (Phase 1)Study completedNCT06147921
What this trial is testing

Phase 1, SAD/MAD of Verasone™ Administered by Sinonasal Irrigation in Healthy Participants

Who this might be right for
Healthy Volunteers
Diceros Therapeutics 46
Early research (Phase 1)Study completedNCT03929016
What this trial is testing

Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects

Who this might be right for
Visceral LeishmaniasisCutaneous Leishmaniases
Drugs for Neglected Diseases 64
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation